Jiang Hong-Li, Xue Wu-Jun, Li Da-Qing, Yin Ai-Ping, Xin Xia, Li Chun-Mei, Gao Ju-Lin
Department of Hemodialysis Center, The First Hospital of Xi'an Jiaotong University, No.1 Jiankang Lu, Xi'an 710061, Shaanxi Province, China.
World J Gastroenterol. 2005 Aug 21;11(31):4815-21. doi: 10.3748/wjg.v11.i31.4815.
To investigate whether continuous veno-venous hemofiltration (CVVH) in different filtration rate to eliminate cytokines would result in different efficiency in acute pancreatitis, whether the saturation time of filter membrane was related to different filtration rate, and whether the onset time of CVVH could influence the survival of acute pancreatitis.
Thirty-seven patients were classified into four groups randomly. Group 1 underwent low-volume CVVH within 48 h of the onset of abdominal pain (early CVVH, n = 9). Group 2 received low-volume CVVH after 96 h of the onset of abdominal pain (late CVVH, n = 10). Group 3 underwent high-volume CVVH within 48 h of the onset of abdominal pain (early CVVH, n = 9). Group 4 received high-volume CVVH after 96 h of the onset of abdominal pain (late CVVH, n = 9). CVVH was sustained for at least 72 h. Blood was taken before hemofiltration, and ultrafiltrate was collected at the start of CVVH and every 12 h during CVVH period for the purpose of measuring the concentrations of TNF-alpha, IL-1beta and IL-6. The concentrations of TNF-alpha, IL-1beta and IL-6 were measured by swine-specific ELISA. The Solartron 1 255 B frequency response analyzer (British) was used to observe the resistance of filter membrane.
The survival rate had a significant difference (94.44% vs 68.42%, P<0.01) high-volume and low-volume CVVH patients. The survival rate had also a significant difference (88.89% vs 73.68%, P<0.05) between early and late CVVH patients. The hemodynamic deterioration (MAP, HR, CVP) was less severe in groups 4 and 1 than that in group 2, and in group 3 than in group 4. The adsorptive saturation time of filters membranes was 120-180 min if the filtration rate was 1 000-4 000 mL/h. After the first, second and third new hemofilters were changed, serum TNF-alpha concentrations had a negative correlation with resistance (r: -0.91, -0.89, and -0.86, respectively in group 1; -0.89, -0.85, and -0.76, respectively in group 2; -0.88, -0.92, and -0.82, respectively in group 3; -0.84, -0.87, and -0.79, respectively in group 4). The decreasing extent of TNF-alpha, IL-1beta and IL-6 was significantly different between group 3 and group 1 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.01), between group 4 and group 2 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.01), between group 1 and group 2 (TNF-alpha P<0.05, IL-1beta P<0.05, IL-6 P<0.05), and between group 3 and group 4 (TNF-alpha P<0.01, IL-1beta P<0.01, IL-6 P<0.05), respectively during CVVH period. The decreasing extent of TNF-alpha and IL-1beta was also significantly different between survival patients and dead patients (TNF-alpha P<0.05, IL-1beta P<0.05). In survival patients, serum concentration of TNF-alpha and IL-1beta decreased more significantly than that in dead patients.
High-volume and early CVVH improve hemodynamic deterioration and survival in acute pancreatitis patients. High-volume CVVH can eliminate cytokines more efficiently than low-volume CVVH. The survival rate is related to the decrease extent of TNF-alpha and IL-1beta. The adsorptive saturation time of filter membranes are different under different filtration rate condition. The filter should be changed timely once filter membrane adsorption is saturated.
探讨不同滤过率的连续性静脉-静脉血液滤过(CVVH)清除细胞因子对急性胰腺炎的疗效是否不同,滤器膜的饱和时间与不同滤过率是否相关,以及CVVH的开始时间是否会影响急性胰腺炎患者的生存率。
将37例患者随机分为四组。第1组在腹痛发作48小时内接受小剂量CVVH(早期CVVH,n = 9)。第2组在腹痛发作96小时后接受小剂量CVVH(晚期CVVH,n = 10)。第3组在腹痛发作48小时内接受大剂量CVVH(早期CVVH,n = 9)。第4组在腹痛发作96小时后接受大剂量CVVH(晚期CVVH,n = 9)。CVVH持续至少72小时。在血液滤过前采血,在CVVH开始时及CVVH期间每12小时收集超滤液,以测定肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)的浓度。采用猪特异性酶联免疫吸附测定法(ELISA)测定TNF-α、IL-1β和IL-6的浓度。使用Solartron 1 255 B频率响应分析仪(英国)观察滤器膜的阻力。
大剂量和小剂量CVVH患者的生存率有显著差异(94.44%对68.42%,P<0.01)。早期和晚期CVVH患者的生存率也有显著差异(88.89%对73.68%,P<0.05)。第4组和第1组的血流动力学恶化(平均动脉压、心率、中心静脉压)比第2组轻,第3组比第4组轻。如果滤过率为1 000 - 4 000 mL/h,滤器膜的吸附饱和时间为120 - 180分钟。更换第一、第二和第三个新的血液滤器后,血清TNF-α浓度与阻力呈负相关(第1组分别为r = -0.91、-0.89和-0.86;第2组分别为-0.89、-0.85和-0.76;第3组分别为-0.88、-0.92和-0.82;第4组分别为-0.84、-0.87和-0.79)。在CVVH期间,第3组和第1组之间、第4组和第2组之间、第1组和第2组之间以及第3组和第4组之间TNF-α、IL-1β和IL-6的下降程度有显著差异(TNF-α P<0.05,IL-1β P<0.05,IL-6 P<0.01)。存活患者和死亡患者之间TNF-α和IL-1β的下降程度也有显著差异(TNF-α P<0.05,IL-1β P<0.05)。在存活患者中,血清TNF-α和IL-1β浓度的下降比死亡患者更显著。
大剂量和早期CVVH可改善急性胰腺炎患者的血流动力学恶化情况并提高生存率。大剂量CVVH比小剂量CVVH能更有效地清除细胞因子。生存率与TNF-α和IL-1β的下降程度有关。在不同滤过率条件下,滤器膜的吸附饱和时间不同。一旦滤器膜吸附饱和,应及时更换滤器。